These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 19262672)
1. Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Brinster S; Lamberet G; Staels B; Trieu-Cuot P; Gruss A; Poyart C Nature; 2009 Mar; 458(7234):83-6. PubMed ID: 19262672 [TBL] [Abstract][Full Text] [Related]
2. Drug discovery: Not as fab as we thought. Zlitni S; Brown ED Nature; 2009 Mar; 458(7234):39-40. PubMed ID: 19262660 [No Abstract] [Full Text] [Related]
3. Type II Fatty Acid Synthesis Pathway and Cyclopropane Ring Formation Are Dispensable during Enterococcus faecalis Systemic Infection. Hays C; Lambert C; Brinster S; Lamberet G; du Merle L; Gloux K; Gruss A; Poyart C; Fouet A J Bacteriol; 2021 Sep; 203(20):e0022121. PubMed ID: 34309397 [TBL] [Abstract][Full Text] [Related]
6. How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics. Yao J; Rock CO J Biol Chem; 2015 Mar; 290(10):5940-6. PubMed ID: 25648887 [TBL] [Abstract][Full Text] [Related]
11. (p)ppGpp/GTP and Malonyl-CoA Modulate Staphylococcus aureus Adaptation to FASII Antibiotics and Provide a Basis for Synergistic Bi-Therapy. Pathania A; Anba-Mondoloni J; Gominet M; Halpern D; Dairou J; Dupont L; Lamberet G; Trieu-Cuot P; Gloux K; Gruss A mBio; 2021 Feb; 12(1):. PubMed ID: 33531402 [TBL] [Abstract][Full Text] [Related]
12. Exogenous fatty acid metabolism in bacteria. Yao J; Rock CO Biochimie; 2017 Oct; 141():30-39. PubMed ID: 28668270 [TBL] [Abstract][Full Text] [Related]
13. Glutathione Synthesis Contributes to Virulence of Walker EA; Port GC; Caparon MG; Janowiak BE J Bacteriol; 2019 Oct; 201(20):. PubMed ID: 31331978 [No Abstract] [Full Text] [Related]
14. Mining Fatty Acid Biosynthesis for New Antimicrobials. Radka CD; Rock CO Annu Rev Microbiol; 2022 Sep; 76():281-304. PubMed ID: 35650664 [TBL] [Abstract][Full Text] [Related]
15. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. Kodali S; Galgoci A; Young K; Painter R; Silver LL; Herath KB; Singh SB; Cully D; Barrett JF; Schmatz D; Wang J J Biol Chem; 2005 Jan; 280(2):1669-77. PubMed ID: 15516341 [TBL] [Abstract][Full Text] [Related]
16. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors. Parsons JB; Frank MW; Subramanian C; Saenkham P; Rock CO Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15378-83. PubMed ID: 21876172 [TBL] [Abstract][Full Text] [Related]